Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: Results from the ALIVE and ISS studies

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 20, Issue 3, 1999, Pages 275-282

  Pezzotti, Patrizio ^a   Galai, Noya ^b   Vlahov, David ^c   Rezza, Giovanni ^a   Lyles, Cynthia M ^c   Astemborki, Jacquie ^c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

AIDS; HIV; Incubation period; Intravenous drug use; Substance abuse

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DISEASE COURSE; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCUBATION TIME; INTRAVENOUS DRUG ABUSE; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; UNITED STATES;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032944895     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199903010-00010     Document Type: Article

References (16)

1. Des Jarlais DC, Friedman SR, Marmor M et al. Development of AIDS, HIV seroconversion, and potential cofactors for T4 cell loss in a cohort of intravenous drug users. AIDS 1987;1:105-11.
2. Peterson PK, Sharp BN, Gekker G, et al. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell co-cultures. AIDS 1990;4:869-74.
3. Pezzotti P, Phillips AN, Dorrucci M, et al. Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. BMJ 1996;313: 583-6.
4. Galai N, Vlahov D, Margolick JB, Chen K, Graham NMH, Muñoz A. Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:66-74.
5. Spijkerman IJB, Langendam NW, Veugelers PJ, et al. Differences in progression to AIDS between injection drug users and homosexual men with documented dates of seroconversion. Epidemiology 1996;7:571-7.
6. Rezza G, Lazzarin A, Angarano G, et al. The natural history of HIV infection in intravenous drug users: risk of disease progression in a cohort of seroconverters. AIDS 1989;3:87-90.
7. Vlahov D, Anthony JC, Muñoz A, et al. The ALIVE Study: a longitudinal study of HIV-1 infection in intravenous drug users: description of methods. J Drug Issues 1991;21:759-76.
8. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41(no. RR-17):1-18.
9. + cell count. JAMA 1998; 279:35-70
10. Muñoz A, Xu J. Models for the incubation of AIDS and variations according to age and period. Stat Med 1996;15:2459-73.
11. Rosenberg PS, Goedert JJ, Biggar RJ for the Multicentric Hemophilia Cohort Study and the International Registry of Seroconverters. Effect of age at seroconversion on the natural AIDS incubation distribution. AIDS 1994;8:803-10.
12. Carrè N, Deveau C, Belanger F, et al. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. AIDS 1994;8:797-802.
13. Operskalski EA, Stram DO, Lee H, et al. Human immunodeficiency virus type 1 infection. Relation of risk group and age to rate of progression to AIDS. J Infect Dis 1995;172:648-55.
14. Margolick JB, Muñoz A, Vlahov D, et al. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection. JAMA 1992;267:1631-6.
15. Crum R, Galai N, Cohn S, Celentano DD, Vlahov D. Alcohol use and T-lymphocyte subsets among injecting drug users with HIV-1 infection: a prospective analysis. Alcohol Clin Exp Res 1996;20: 364-71.
16. Lyles CN, Margolick JB, Astemborski J, et al. The influence of drug use patterns on the rate of CD4-lymphocyte decline among HIV-1 infected injecting drug users. AIDS 1997, 11:1255-62.